Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: A Cross Sectional Study from the TARGET-DERM AD Cohort.
Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: A Cross Sectional Study from the TARGET-DERM AD Cohort (Fall Clinical 2022)
Challenge
This is a Fall Clinical 2022 poster version of the same head, neck, face, and hand AD burden study as Row 10 (manuscript 2023) and Row 39 (RAD 2021 poster). Conference presentation of the finding that 85% of moderate-to-severe AD patients have difficult-to-treat site involvement with significantly worse QoL.
Solution
TARGET-DERM AD cohort cross-sectional analysis of head, neck, face, and hand involvement prevalence and HRQoL impact using POEM and DLQI/CDLQI.
Impact
Fall Clinical 2022 poster dissemination expands the reach of the difficult-to-treat site burden findings to the broader dermatology community, supporting label development and prescriber awareness for therapies targeting AD at high-impact anatomical locations.
